NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

JW LIFESCIENCE CORPORATION Logo
Specialized manufacturer of infusion solutions and advanced nutrient IV fluids.
South Korea
234080
JW PHARMACEUTICAL Logo
Develops and commercializes pharmaceuticals, OTC solutions, and nutritional infusions.
South Korea
001060
JW SHINYAK CORPORATION Logo
Develops and sells medicines, specializing in dermatology and urology treatments.
South Korea
067290
Jyong Biotech Ltd. Logo
Develops plant-derived drugs for urinary system diseases, with a drug in Phase III.
United States of America
MENS
kainos loboratories,inc Logo
Develops and manufactures in-vitro diagnostics and clinical testing reagents.
Japan
4556
KAKEN PHARMACEUTIAL CO., LTD. Logo
Develops and markets pharmaceuticals for dermatology, orthopedics, and surgery.
Japan
4521
KALA BIO, Inc. Logo
Clinical-stage biopharma developing therapies for rare and severe eye diseases.
United States of America
KALA
Kalaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing treatments for retinal diseases.
United States of America
KLRS
KalVista Pharmaceuticals, Inc. Logo
Develops oral therapies for rare diseases, with a primary focus on HAE.
United States of America
KALV
Kamada Ltd. Logo
A biopharmaceutical company specializing in plasma-derived protein therapeutics.
Israel
KMDA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.